We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Caffeine Shown to Block Cholesterol to Brain

By Biotechdaily staff writers
Posted on 29 Apr 2008
Daily intake of caffeine has been shown to block the deleterious effects of high cholesterol that scientists have linked to Alzheimer's disease. More...


A study slated to be published in the open access publication, Journal of Neuroinflammation revealed that caffeine equivalent to just one cup of coffee per day could protect the blood-brain barrier (BBB) from damage that occurred with a high-fat diet. The BBB protects the central nervous system from the rest of the body's circulation, providing the brain with its own controlled microenvironment. Earlier studies have demonstrated that high levels of cholesterol break down the BBB, which can then no longer protect the central nervous system from the damage caused by blood-borne contamination. BBB leakage occurs in a host of neurologic disorders such as Alzheimer's disease.

In this study, researchers from the University of North Dakota School of Medicine and Health Sciences (Grand Forks, USA) gave rabbits 3 mg caffeine each day--the equivalent of a daily cup of coffee for an average-sized person. The rabbits were fed a cholesterol-enriched diet during this time. After 12 weeks, a number of laboratory tests demonstrated that the BBB was significantly intact in rabbits receiving a daily dose of caffeine.

"Caffeine appears to block several of the disruptive effects of cholesterol that make the blood-brain barrier leaky,” reported Dr. Jonathan Geiger, from the University of North Dakota School of Medicine and Health Sciences. "High levels of cholesterol are a risk factor for Alzheimer's disease, perhaps by compromising the protective nature of the blood-brain barrier. For the first time we have shown that chronic ingestion of caffeine protects the BBB from cholesterol-induced leakage.”

Caffeine appears to protect BBB breakdown by maintaining the expression levels of tight junction proteins. These proteins bind the cells of the BBB tightly to each other to stop unwanted molecules crossing into the central nervous system. These findings validated and extend results from other studies showing that caffeine intake protects against memory loss in aging and in Alzheimer's disease.

"Caffeine is a safe and readily available drug and its ability to stabilize the blood-brain barrier means it could have an important part to play in therapies against neurological disorders,” stated Dr.Geiger.


Related Links:
University of North Dakota School of Medicine and Health Sciences

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Cancer-specific small RNAs released into blood act as molecular barcodes that reveal tumor identity (Photo courtesy of Arc Institute)

Blood Test Could Detect Molecular Barcodes Capable of Distinguishing Cancer Types

Some cancers are difficult to classify, track, and monitor after treatment, posing a major clinical challenge. Many tumors shed little DNA into the bloodstream, making it hard to detect minimal residual... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.